Mi SciELO
Servicios Personalizados
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Revista Cubana de Medicina Militar
versión On-line ISSN 1561-3046
Resumen
CASTILLO DEPRES, Saymara et al. Heberprot-P in the treatment of diabetic foot ulcers. Rev Cub Med Mil [online]. 2022, vol.51, n.3 Epub 01-Sep-2022. ISSN 1561-3046.
Introduction:
The diabetic foot is one of the most feared complications of diabetes mellitus; It is the cause of 80 % of non-traumatic amputations worldwide. For decades, different treatments have been used to heal diabetic foot; growth factors have revolutionized this therapy. The participation of a multidisciplinary team with compliance with the action protocols and the use of Heberprot-P decrease the rate of amputations in patients with this condition.
Objective:
To present the evolution of patients with diabetic foot ulcers, in different clinical stages, treated with Heberprot-P.
Development:
Three clinical cases are presented; The first is a male patient, 56 years old, diabetic, with open transmetatarsal amputation in which 16 applications of Heberprot-P were performed and a skin graft was placed, the lesion closed in 45 days. The second is a 58-year-old patient, diabetic and hypertensive, with a right foot injury, with previous vascular surgery; 19 applications of Heberprot-P were performed and the lesion healed in 49 days. The third case is a 55-year-old patient, who was admitted due to an extensive injury to his right foot, 22 applications of Heberprot-P were performed, closure of the injury was achieved in 85 days and amputation was avoided.
Conclusions:
The presented cases evolved favorably with Heberprot-P treatment.